The Company ended the first quarter of 2024 with $9.8 million in cash, investments and accrued interest receivable. The Company believes it has sufficient capital resources to fund its operations to the end of 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMNN:
- IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
- Is IMNN a Buy, Before Earnings?
- Imunon Appoints Stacy R. Lindborg as New President and CEO
- Imunon appoints Lindborg as President, CEO
- IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024
